Literature DB >> 15862889

The APOC3 SstI polymorphism is weakly associated with sporadic Alzheimer's disease in a Chinese population.

Yan Sun1, Jiajun Shi, Sizhong Zhang, Mouni Tang, Haiying Han, Yangbo Guo, Cui Ma, Xiehe Liu, Tao Li.   

Abstract

In order to clarify the relationship of apolipoprotein CIII (APOC3) polymorphism and sporadic Alzheimer's disease (AD) in Chinese, 165 sporadic AD patients and 174 age-matched elderly individuals were genotyped for the APOC3 SstI and apolipoprotein E (APOE) HhaI polymorphisms. As the result, the APOC3 3017G allele was found to be associated with AD in APOE epsilon4 allele noncarriers (chi2=4.433, P=0.035), and the risk estimate of allele C versus G resulted in an OR of 1.56 (95% CI: 1.03-2.37), although in total no significant differences of allelic or genotypic frequencies between patients and controls were found. Assessment of interaction between APOE epsilon4 and APOC3 3017G status presented an adjusted odds ratio of 0.62 (95% CI: 0.37-1.03) with a borderline significant P-value (P=0.066). Therefore, we conclude that the rare APOC3 G allele may offer some protection against the development of sporadic AD in APOE epsilon4 noncarriers in Chinese.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15862889     DOI: 10.1016/j.neulet.2005.01.038

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.

Authors:  Rui-Nan Zhang; Rui-Dan Zheng; Yu-Qiang Mi; Da Zhou; Feng Shen; Guang-Yu Chen; Chan-Yan Zhu; Qin Pan; Jian-Gao Fan
Journal:  Dig Dis Sci       Date:  2016-04-08       Impact factor: 3.199

2.  Apolipoprotein C3 polymorphisms, cognitive function and diabetes in Caribbean origin Hispanics.

Authors:  Caren E Smith; Katherine L Tucker; Tammy M Scott; Maria Van Rompay; Josiemer Mattei; Chao-Qiang Lai; Laurence D Parnell; Mireia Junyent; Yu-Chi Lee; Bibiana Garcia-Bailo; José M Ordovás
Journal:  PLoS One       Date:  2009-05-08       Impact factor: 3.240

3.  High density lipoprotein and its apolipoprotein-defined subspecies and risk of dementia.

Authors:  Manja Koch; Steven T DeKosky; Matthew Goodman; Jiehuan Sun; Jeremy D Furtado; Annette L Fitzpatrick; Rachel H Mackey; Tianxi Cai; Oscar L Lopez; Lewis H Kuller; Kenneth J Mukamal; Majken K Jensen
Journal:  J Lipid Res       Date:  2019-12-31       Impact factor: 5.922

4.  Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease.

Authors:  Richard J Perrin; Rebecca Craig-Schapiro; James P Malone; Aarti R Shah; Petra Gilmore; Alan E Davis; Catherine M Roe; Elaine R Peskind; Ge Li; Douglas R Galasko; Christopher M Clark; Joseph F Quinn; Jeffrey A Kaye; John C Morris; David M Holtzman; R Reid Townsend; Anne M Fagan
Journal:  PLoS One       Date:  2011-01-12       Impact factor: 3.240

5.  Gene expression profiling and association with prion-related lesions in the medulla oblongata of symptomatic natural scrapie animals.

Authors:  Hicham Filali; Inmaculada Martin-Burriel; Frank Harders; Luis Varona; Jaber Lyahyai; Pilar Zaragoza; Martí Pumarola; Juan J Badiola; Alex Bossers; Rosa Bolea
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

6.  Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population.

Authors:  FengHe Cui; KeZhong Li; YunFeng Li; XueWu Zhang; ChangShan An
Journal:  Lipids Health Dis       Date:  2014-11-08       Impact factor: 3.876

Review 7.  Functional Roles of the Interaction of APP and Lipoprotein Receptors.

Authors:  Theresa Pohlkamp; Catherine R Wasser; Joachim Herz
Journal:  Front Mol Neurosci       Date:  2017-03-01       Impact factor: 5.639

8.  Higher Plasma APOC-III Was Associated with a Slower Reduction of β-Amyloid Levels in Cerebrospinal Fluid Among Older Individuals Without Dementia.

Authors:  Xiaoyan Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-05-05       Impact factor: 2.570

9.  Decreased expression of the APOA1-APOC3-APOA4 gene cluster is associated with risk of Alzheimer's disease.

Authors:  Qiao Lin; Yunpeng Cao; Jie Gao
Journal:  Drug Des Devel Ther       Date:  2015-09-29       Impact factor: 4.162

10.  Apolipoproteins and Alzheimer's pathophysiology.

Authors:  Manja Koch; Steven T DeKosky; Annette L Fitzpatrick; Jeremy D Furtado; Oscar L Lopez; Lewis H Kuller; Rachel H Mackey; Timothy M Hughes; Kenneth J Mukamal; Majken K Jensen
Journal:  Alzheimers Dement (Amst)       Date:  2018-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.